This article needs additional citations for verification. Please help improve this article by adding reliable references. Unsourced material may be challenged and removed. (September 2008)

Barr Pharmaceuticals Inc

Type	Delaware Corporation
Founded	New York (1970)
Headquarters	Montvale, NJ, USA
Key people	Bruce Downey, CEO
Industry	Pharmaceuticals & Medical Devices
Products	Generic and Proprietary Pharmaceuticals
Revenue	Over $1 Billion USD fiscal year 2005
Employees	2000
Website	http://www.barrlabs.com

Barr Pharmaceuticals, Inc., was a global specialty pharmaceutical company that operated in more than 30 countries worldwide. Barr were engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals, biopharmaceuticals and active pharmaceutical ingredients.

[edit] History

Barr Laboratories, Inc. was founded in 1970 by Edwin A. Cohen and was ultimately taken public under his leadership.

On July 18, 2008 it was announced that rival firm - Teva Pharmaceutical Industries Ltd, would acquire Barr Pharmaceuticals Inc for $7.46 billion plus the assumption of net debt of approximately $1.5 billion.^[1] Today Barr Laboratories exists only as a sub-division of Teva Pharmaceuticals.

Teva Pharmaceuticals develops and markets generic pharmaceuticals under various brand names - including the Barr Laboratories, Inc. label. Teva Pharmaceuticals is the largest generic drug manufacturer in the world.

[edit] References

[edit] External links

• Barr Pharmaceutical Corporate Website